Outcomes Following Percutaneous Coronary Intervention in Patients Previously Considered “Without Option”:

Harray C. Lowe, Stephen N. Oesterle, Kunlun He, Briain D. MacNeill, Daniel BurkhoffJournal of Interventional Cardiology 2004 · DOI

TL;DR

This study investigates the effectiveness of Percutaneous Coronary Intervention (PCI) in patients with severe coronary artery disease who were previously deemed "no-option" for traditional treatments. The findings suggest that PCI offers only marginal, if any, symptomatic benefit to this challenging patient group, highlighting a need for further evaluation of treatment strategies.

What Problem Does This Paper Address?

Patients with advanced coronary artery disease (CAD) who experience intractable symptoms despite optimal medical therapy and are not candidates for coronary artery bypass grafting (CABG) or standard PCI represent a significant clinical challenge. Historically, these individuals have been labeled "no-option" patients, often relegated to experimental therapies. While percutaneous transmyocardial revascularization (PTMR) was one such experimental approach explored in the PACIFIC trial, a subset of these "no-option" patients subsequently underwent PCI. The problem this paper addresses is the unknown clinical outcome of PCI in this specific, previously underserved patient population, particularly when they have already been deemed unsuitable for such interventions.

Methods

This study employed a retrospective analysis of data collected from the Potential Angina Class Improvement From Intramyocardial Channels (PACIFIC) trial. The researchers focused on a subgroup of 21 patients who, despite initially being considered "no-option" and randomized to either PTMR or medical therapy, subsequently underwent PCI within 12 months of the trial's follow-up period. The analysis compared clinical outcomes before and after PCI, utilizing metrics such as the Canadian Cardiovascular Society Angina Scale, exercise tolerance tests, and the Seattle Angina Questionnaire. Statistical comparisons were made using Fisher's exact test, Wilcoxon's test, and paired t-tests with Bonferroni correction for multiple comparisons.

Datasets

The data for this study were derived from the PACIFIC trial, a prospective, randomized, multicenter study. The specific dataset analyzed comprised 21 patients from the PACIFIC trial who underwent PCI outside of the original protocol. Baseline assessments included echocardiograms, dipyridamole thallium stress tests, exercise treadmill tests, and the Seattle Angina Questionnaire. Follow-up evaluations at 3, 6, and 12 months included the Canadian Cardiovascular Society Angina Scale, exercise tolerance tests, and the Seattle Angina Questionnaire.

Key Insights and Ideas

  • PCI's Limited Impact on "No-Option" Patients: The most striking insight is that PCI, even when performed successfully in patients previously deemed unsuitable, yields only modest, often statistically nonsignificant, improvements in symptoms and quality of life.
  • Prior PTMR Doesn't Enhance PCI Benefit: For patients who had previously undergone PTMR, PCI did not appear to provide additional symptomatic relief or functional improvement beyond what was already observed after PTMR.
  • Medical Group Shows Some Post-PCI Improvement: Patients in the medical therapy group who underwent PCI did show some improvement in angina class and exercise tolerance, but this improvement largely occurred after the PCI procedure, suggesting PCI was the driver of change in this subset.
  • High Baseline Risk Factors: The study population exhibited a high prevalence of cardiovascular risk factors (hypertension, diabetes, hyperlipidemia) and a history of prior revascularization procedures (CABG and/or PCI), which are factors that can complicate outcomes.
  • Small Sample Size Limits Generalizability: While the findings are consistent with a hypothesis of limited benefit, the small sample size of 21 patients means the results lack statistical power and warrant further investigation.

Key Results

  • Angina Class: Overall, a reduction in angina class was observed from baseline to post-PCI in both the medical and PTMR groups. However, in the PTMR group, the majority of this reduction occurred before PCI, with no significant change after PCI. In the medical group, the reduction largely occurred post-PCI.
  • Exercise Duration: Similar, statistically nonsignificant increases in mean exercise duration were observed from baseline to post-PCI in both groups. The medical group showed an improvement primarily post-PCI, while the PTMR group saw most of their improvement from baseline to pre-PCI, with no significant change following PCI.
  • Quality of Life: The Seattle Angina Questionnaire revealed no significant improvements in quality of life following PCI in either group, with the exception of a slightly improved "Anginal Stability" index in the medical group.
  • Adverse Events: The most frequent adverse event was hospitalization for angina. Two deaths occurred during the follow-up period, one in each group, approximately 200 days after enrollment and about 4 months after PCI.

Limitations and Future Work

The authors explicitly acknowledge that the patient population in this study is small, non-randomized, and lacks statistical power. This limits the generalizability of the findings. The retrospective nature of the analysis also means that the PCI procedures were performed "out of protocol," potentially introducing variability.

Future work should focus on larger, prospective trials specifically designed to evaluate PCI outcomes in this "no-option" patient population. Given the persistent challenges in managing these patients, further research is warranted to explore alternative treatment strategies or refine existing ones to provide more substantial and consistent benefits. The study suggests that for patients with severe, refractory angina who are considered unsuitable for PCI, the benefits of such an intervention may be marginal at best, prompting a critical re-evaluation of treatment pathways.

Summary updated

Abstract

These data suggest that PCI provides only marginal-if any-symptomatic benefit in these patients.
BibTeX
@article{lowe2004outcomes,
  author = {HARRAY C. LOWE and Stephen N. Oesterle and Kunlun He and Briain D. MacNeill and Daniel Burkhoff},
  title = {{Outcomes Following Percutaneous Coronary Intervention in Patients Previously Considered “Without Option”:}},
  journal = {Journal of Interventional Cardiology},
  year = {2004},
  doi = {10.1111/j.1540-8183.2004.00325.x},
}
Figure